FIELD: chemistry.
SUBSTANCE: invention concerns novel compounds of the formula (I): , where R1 is -COOH or -(CH2)n-R14; R2 is or , where X is -CH or -N; each of R3, R4, R5 and R6 is selected out of group including -H, -(lower) alkyl, -N(CH3)2, -O-(lower) alkene, -(lower) alcoxy, or where R5 and R6 are substitutes in adjoining carbon atoms in ring, R5 and R6 optionally form 5- or 6-member saturated carbocyclic ring together with adjoining carbon atoms, R14 is unsaturated 5-member substituted or non-substituted heterocyclic ring including 1 to 4 heteroatoms selected out of N, O and S, n is 0 or 1, or their pharmaceutically acceptable salts or complex ethers. Invention also concerns pharmaceutical composition.
EFFECT: obtaining new bioactive compounds and pharmaceutical composition based on them, with inhibition effect on glutamine fructose-6-phosphate amidotransferase (GFAT).
16 cl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
4,6,7,13-SUBSTITUTED DERIVATIVES OF 1-BENZYLISOQUINOLINE AND PHARMACEUTICAL COMPOSITION POSSESSING INHIBITORY ACTIVITY WITH RESPECT TO GFAT | 2004 |
|
RU2320648C2 |
DERIVATIVES OF QUINOLINE XANTHINE AND 8-ISOQUINOLINE XANTHINE AS INHIBITORS OF PHOSPHODIESTERASE PDE-5 | 2001 |
|
RU2269529C2 |
SUBSTITUTED PYRAZOLOPYRIMIDINES, METHOD FOR PREPARING AND USING THEM AS DRUG | 2007 |
|
RU2450004C2 |
DERIVATIVES OF PYRIDO[2,1-A]ISOQUINOLINE AS INHIBITORS OF DPP-IV | 2002 |
|
RU2297417C2 |
METHOD OF SYNTHESIS OF 3-AMINOISOQUINOLINE DERIVATIVES | 1987 |
|
SU1540231A1 |
NOVEL 2,4-DIAMINOTHIAZOL-5-ONE DERIVATIVES | 2005 |
|
RU2395501C2 |
CIS-IMIDAZOLINES AS MDM2 INHIBITORS | 2004 |
|
RU2354649C2 |
HEXAHYDROPYRIDOISOQUINOLINES AS DIPEPTIDYL PEPTIDASE IV (DPPIV) INHIBITORS | 2004 |
|
RU2339636C2 |
COUMARONE DERIVATIVES ELICITING COMT-INHIBITING ACTIVITY | 2001 |
|
RU2282627C2 |
2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2661197C2 |
Authors
Dates
2009-05-20—Published
2004-10-07—Filed